Novan announced positive ppreclinical data in SB019 COVID-19 anti-viral therapy program
On Jun. 10, 2021, Novan announced positive preclinical results with berdazimer sodium in a SARS-CoV-2 transmission model in…
Pfizer and BioNTech provided 500 million doses of COVID-19 vaccine to U.S. Government for donation to poorest nations
On Jun. 10, 2021, Pfizer and BioNTech announced plans to provide the U.S. government at a not-for-profit price…
Vertex announces FDA approval for TRIKAFTAﾮ in children with Cystic Fibrosis ages 6 through 11 with certain mutations
On Jun. 9, 2021, Vertex Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved expanded use of…
Roche obtained CE mark for SARS-CoV-2 antigen self test nasal allowing for rapid self testing of COVID-19 at home
On Jun. 8, 2021, Roche announced it had received CE mark for its SARS-CoV-2 Antigen Self Test Nasal…
Merck announced supply agreement with U.S. Government for molnupiravir, an Investigational oral antiviral treatment of COVID-19
On Jun. 8, 2021, Merck announced it had entered into a procurement agreement with the U.S. government for…
Pixel by Labcorpﾮ COVID-19 PCR test home collection kits now available nationwide
On Jun. 8, 2021, LabCorp announced that its Pixel COVID-19 PCR Test Home Collection Kits were availavle in…
FDA approved PREVNAR 20ﾙ, Pfizerﾒs pneumococcal 20-valent conjugate vaccine for adults ages 18 years or older
On Jun. 8, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PREVNAR 20ﾙ…
Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2
On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…
FDA granted accelerated approval for ADUHELMﾙ as the first and only Alzheimerﾒs disease treatment
On Jun. 7, 2021, Biogen and Eisai announced that the U.S. Food and Drug Administration (FDA) had granted…
OraSure Technologies receives three EUA’s for its COVID-19 rapid antigen tests for non-prescription use
On Jun. 7, 2021, OraSure Technologies announced that it had received Emergency Use Authorization (EUA) from the FDA…
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
FDA approved new drug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
Chimerix received U.S. FDA approval for TEMBEXAﾮ (brincidofovir) for treatment of smallpox
On Jun. 4, 2021, Chimerix announced that the U.S. Food and Drug Administration (FDA) had granted TEMBEXAﾮ (brincidofovir)…
Resverlogix and EVERSANA announced partnership to support commercialization of Apabetalone for COVID-19 in U.S. and Canada
On Jun. 3, 2021, Resverlogix announced a partnership to support planned commercialization of apabetalone in the United States,…
NIH researchers identified potential new antiviral drug for COVID-19
On Jun. 3, 2021, the National Institutes of Health announced that the experimental drug TEMPOL may be a…
Innovation Pharma completed enrollment in phase 2 clinical trial for COVID-19
On Jun. 3, 2021, Innovation Pharma announced that it had achieved full patient enrollment in its randomized, double-blind,…
Relief Therapeutics reported that NRx Pharma, had submitted an application for EUA for Aviptadil to the U.S. FDA
On Jun. 2, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, announced that it had submitted…
Vaxxas and collaborators revealed potential of Vaxxasﾒ high-density microarray patch to deliver SARS-CoV-2 vaccine
On Jun. 2, 2021, Vaxxas announced that research demonstrated the potential of Vaxxasﾒ novel high-density microarray patch (HD-MAP)…
Scientists discovered a new genetic form of ALS in children
On Jun. 1, 2021, in a study of 11 medical-mystery patients, an international team of researchers led by…
U.S. blood donations declared safe under current COVID-19 screening guidelines
On Jun. 1, 2021, a study by researchers at the National Institutes of Health and their colleagues found…
WHO validated Sinovac COVID-19 vaccine for emergency use
On Jun. 1, 2021, WHO validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies…
NIH clinical trial evaluating mixed COVID-19 vaccine schedules began
On Jun. 1, 2021, the National Institutes of Health announced that it had started a Phase 1/2 clinical…
DSMB confirmed CureVac pivotal phase 2b/3 study for first-generation COVID-19 vaccine candidate
On May 28, 2021, CureVac announced that the independent Data Safety Monitoring Board (DSMB)confirmed that the pivotal Phase…
University of Oxford launched Pandemic Sciences Centre
On May 28, 2021, the University of Oxford announced the launch of a new centre of global research…
Humanigen submitted application to FDA for Emergency Use Authorization for lenzilumab in COVID-19
On May 28, 2021, Humanigen announced that the company had submitted an application to the FDA requesting Emergency…
Omeros announced preliminary results from additional critically Ill COVID-19 patients treated with narsoplimab
On May 28, 2021, Omeros announced preliminary results from the second cohort of critically ill COVID-19 patients treated…
Novartis and Molecular Partners announced start of EMPATHY clinical trial for ensovibep for treatment of COVID-19
On May 27, 2021, Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase…
Patient enrollment reached 90 percent in Innovation Pharmaceuticals phase 2 clinical trial of Brilacidin for COVID-19
On May 27, 2021, Innovation Pharmaceuticals announced that patient enrollment in the Companyﾒs 120-patient, Phase 2 clinical trial…
Sanofi and GSK initiated global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
On May 27, 2021, Sanofi and GlaxoSmithKline started enrolment in their Phase 3 clinical study to assess the…
Altimmune demonstrated strong neutralization of South African variant in preclinical study of intranasal AdCOVIDﾙ
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…